Implant, a mandrel, and a method of forming an implant

Information

  • Patent Grant
  • 8801747
  • Patent Number
    8,801,747
  • Date Filed
    Wednesday, February 27, 2008
    16 years ago
  • Date Issued
    Tuesday, August 12, 2014
    10 years ago
Abstract
This invention is directed to an implant having a coil for embolizing a vascular site, such as aneurysm. The coil has a specific three-dimensional shape that is achieved by winding the coil around a mandrel in a specific pattern and then heat setting the coil and the mandrel, another aspect of the invention. The three-dimensional shape resembles unclosed mobius loops. Also provided are methods of making the coil and methods of embolizing vascular site.
Description
FIELD OF THE INVENTION

This invention relates to the forming of implantable coils and to coils formed by such methods as well as to a mandrel used to form the shape of a coil implant, a method of forming a coil implant, and a coil implant formed by such method or with such mandrel.


BACKGROUND OF THE INVENTION

Implants are delivered to a vascular site, such as an aneurysm, of a patient via a microcatheter to occlude or embolize the vascular site. Typically, the implant is engaged at the distal end of either the delivery microcatheter or the guidewire contained within the microcatheter and controllably released therefrom into the vascular site to be treated. The clinician delivering the implant must navigate the microcatheter or guide catheter through the vasculature and, in the case of intracranial aneurysms, navigation of the microcatheter is through tortuous microvasculature. This delivery may be visualized by fluoroscopy or another suitable means. Once the distal tip of the catheter or guidewire is placed in the desired vascular site, the clinician must then begin to articulate the implant in the vascular site to ensure that the implant will be positioned in a manner to sufficiently embolize the site. Once the implant is appropriately positioned, the clinician must then detach the implant from the catheter or guidewire without distorting the positioning of the implant. Detachment may occur through a variety of means, including, electrolytic detachment, chemical detachment, mechanical detachment, hydraulic detachment, and thermal detachment.


Previously, there had been provided 3-dimensional coils which are formed from a straight wire by detachment from the catheter or guidewire. The 3-dimensional coil is typically formed from a metal which upon detachment (e.g., in vivo) reconfigures from the straight wire into a coil shape or confirmation having a secondary structure (i.e., an extended or helically coil confirmation) which under ideal circumstances will comport to the shape of the vascular site to be embolized. However, the in vivo formed coils of the prior art invariably failed to provide shapes which comport to the vascular site and this results in the ineffective embolization of the vascular site. Even when the 3-dimensional coils of the prior art initially comport to the vascular site, the secondary structure of the resulting coils may not be sufficiently stable to retain their comportment with the vascular site. For example, 3-dimensional in vivo formed spherical coils tend to fold upon themselves which leads to secondary structure different from that of the vascular site. Likewise, 3-dimensional in vivo formed cubic coils often collapse on themselves, similar to a “stack of coins” rather than retaining their cubic shape.


In light of the above, there exists a need for a coil implant which substantially conforms to the vascular site to be embolized.


SUMMARY OF THE INVENTION

The invention, in one embodiment, is directed to an implant comprising a 3-dimensional coil designed to optimize packing into a vascular site, such as an aneurysm. It is contemplated that the implant of the invention, due to its secondary shape, is able to substantially conform to a vascular site thereby providing a more effective embolization. In particular, the shape of the 3-dimensional coil of this invention is composed of one or more unclosed mobius loops.


In one embodiment, this invention provides a 3-dimensional vascular coil comprising one or more unclosed mobius loops. The coil is biased to form a pattern corresponding to the winding pattern around a mandrel when released from the catheter or guidewire. The bias disposes the coil into a 3-dimensional shape that conforms with the exterior of a sphere. The winding pattern has at least one unclosed mobius loop distributed over the shape. In other embodiments, the winding pattern has at least two or three unclosed mobius loops distributed over the shape.


The shape of the coil can also conform with a pattern of eight substantially triangular shapes distributed over the surface of a sphere. In one embodiment, the eight substantially triangular shapes include four substantially triangular shapes with sides that bow outwards (convex) away from the center of the respective triangular shape, and four substantially triangular shapes with sides that bow inwards (concave) towards the center of the respective triangular shape. The shape of the coil can also have loops that conform with a path between the substantially triangular shapes, with a path that curves around the center of the sphere while also curving around at least four points corresponding to the triangular shapes, or with a path that can be described as generally following the contour of a hyperbolic parabloid or the contour of a saddle. Depending on the length of the coil, at least one and preferably multiple wraps of the coil will be made around the mandrel according to the winding pattern.


In one embodiment of the invention is provided a method of embolizing a vascular site of a patient comprising delivering the implant just described to the vascular site. The implant is delivered with a delivery device. The delivery device can be a microcatheter optionally including a guidewire and/or a positioner.


Another embodiment of the invention is directed to a mandrel. The mandrel includes a sphere and a plurality of markers, such as four markers, disposed on the exterior surface of the sphere. Optionally, one of the markers includes a stem. Each of the four markers define a pathway between adjacent markers, and the pathway preferably defines a winding pattern for a coil that is to be wrapped around the outer surface of the sphere. The winding pattern includes a series of sequential turns across the surface of the sphere corresponding to points where the pathway is disposed adjacent to a marker. The winding pattern also includes a series of sequential crossing points that correspond to midpoints between adjacent markers on the surface of the sphere.


In another embodiment of the invention is provided a method of forming the implant of the invention. The method of forming the coil includes the process of wrapping the coil over the mandrel according to the winding pattern. The method further includes subjecting the mandrel and wrapped coil to heat. The method also includes additional processing steps that form a finished coil from the wrapped coil.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate exemplary embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain the features of the invention.



FIG. 1A is a plan view of a positioning system used to deliver a coil of the invention.



FIG. 1B is a closer view of a portion of FIG. 1A showing the positioning system in partial cross-section and an exemplary coil in a position within the human body prior to deployment of the coil.



FIG. 1C is a closer view of a portion of FIG. 1A showing the positioning system in partial cross-section and an exemplary implant in another position within the human body after deployment but before detachment.



FIG. 1D is a shows the layup of the coil in the vascular site.



FIG. 2 is a plan view of a mandrel.



FIG. 3 is a top view of the mandrel of FIG. 2.



FIG. 4 is a close-up view of a portion of FIG. 2.



FIG. 5 is an isometric exploded view of the mandrel of FIG. 2.



FIG. 6 is a schematic view of the winding pattern followed by a coil across the surface of the mandrel of FIG. 2, with a portion of the coil and the stem omitted.



FIG. 7A is the schematic view of FIG. 6 with the mandrel omitted.



FIG. 7B shows the schematic of FIG. 7A with the rearward portion of the winding pattern omitted.



FIG. 7C shows a perspective of an unclosed mobius loop.



FIG. 8 is a representation of the winding pattern of FIG. 6.



FIG. 9 and FIG. 10 are plan views of the mandrel of FIG. 2 showing the winding pattern of the coil around the mandrel.





DETAILED DESCRIPTION OF THE INVENTION

Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods, devices, and materials are now described. All publications and patent applications cited herein are incorporated herein by reference in their entirety. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.


It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


Methods of Embolizing a Vascular Site

The implant of the invention may be used to embolize a vascular site. This is best illustrated in FIGS. 1A, 1B, 1C, and 1D, which are described below. It should be noted that this method of delivery is one contemplated embodiment and that the implant of the invention may be delivered by a variety of other methods known by one of skill in the art.


In the embodiment illustrated in FIG. 1A, an operator uses a guide catheter 112 to position a microcatheter 114 in a patient's vasculature. The procedure involves inserting the guide catheter 112 into the patient's vasculature through an access point such as the groin, and directing the distal end 112a of the guide catheter 112 through the vascular system until it reaches the carotid artery. After removing a guide wire (not shown) from the guide catheter 112, a microcatheter 114 is inserted into the guide catheter 112 and the distal end 114a of the microcatheter 114 subsequently exits the guide catheter distal end 112a and is positioned near the target site 116, such as an aneurysm in the patient's brain. As illustrated in FIGS. 1B and 1C, the microcatheter 114 includes microcatheter markers 115 and 115a that facilitate imaging of the distal end 114a of the microcatheter 114 with common imaging systems and, in the illustrated embodiment, the microcatheter markers 115 and 115a are made of a radiopaque material. After the distal end 114a reaches the target site 116, the positioning system (not shown) of the illustrated embodiment is then inserted into the microcatheter 114 to position the implant interface 180 at the distal end of the positioner 140 near the target site 116, as illustrated in FIG. 1C. If the implant 190 is being delivered in the procedure, the implant 190 is attached to the implant interface 180 prior to inserting the positioning system into the microcatheter 114. This mode of implant delivery is illustrated in FIGS. 1A, 1B, and 1C.


The delivery of the implant 190 is facilitated by disposing the microcatheter marker 115a near the target site 116, and aligning the microcatheter marker 115 with a positioner marker 164 in the positioner 140 which, when the two markers (markers 115 and 164) are aligned with each other as illustrated in FIG. 1C, indicates to the operator that the implant interface 180 is in the proper position for the release of the implant 190 from the positioning system (not shown). After depositing the implant 190 at the target site 116, a second implant 190 can be deposited at the target site 116 by removing the positioning system from the microcatheter 114 and inserting a second positioning system with an attached second implant 190 into the microcatheter 114 in a manner similar to the method used with the insertion of the first implant 190. The same procedure can be used for a third implant 190 and subsequent implants if clinically necessary. If the implant 190 is already in the patient's body to be retrieved or repositioned, the positioning system is inserted into the microcatheter 114 without the implant 190.


The Mandrel, the Implant, and the Method of Making the Implant

The invention, in one embodiment, is directed to an implant having a coil length that is biased to conform to a winding pattern, the winding pattern approximately conforming to a shape of an outer surface of a sphere. The winding pattern has at least one unclosed mobius loop (or a plurality of unclosed mobius loops) distributed over the shape. A mobius loop is formed by bringing the ends of that same coil around and twisting one end half of a turn before joining the ends. In this invention, the mobius loop is unclosed meaning the ends are not joined. This is best illustrated in FIG. 7C. A mobius loop is a strip having a single surface and is chiral.


To achieve the mobius loop, a mandrel is employed. The mandrel 10 illustrated in FIGS. 2 and 3 includes a sphere 20, four markers, and optionally a stem 30. The markers are mounted on the external surface of the sphere 20 at four locations. Each marker is designated with a numeric identifier of 1, 2, 3, or 4 as illustrated in FIGS. 2 and 3. Specifically, the stem 30 extends from marker 4. Marker 1 is on the left side of FIGS. 2 and 3 and is identifiable because it includes a starter tube 40. Marker 3 is to the right of marker 1 in FIG. 2 and to the bottom right in FIG. 3. Marker 2 is not viewable in FIG. 2 because it is on the rearward side of the figure, and is illustrated on the top right side in FIG. 3. FIG. 5 illustrates an isometric assembly view of the mandrel 10 without the starter tube 40.


The markers 1, 2, 3, and 4 are cylindrical and define longitudinal axes 11, 12 (not shown, but refers to the axis through marker 2), 13, and 14 for markers 1, 2, 3, and 4, respectively. Each axis 11, 12, 13, and 14 passes through the center of the sphere 20. The longitudinal axis 14 also passes through the center of the stem 30. The axes 11, 12, and 13 are at a vertical angle 50 to a plane 52 that is orthogonal to the axis 14, as illustrated in FIG. 2, which is about 19.5 degrees ±2.5 degrees. The axes 11, 12, and 13 are also at a horizontal angle 54 relative to each other, as illustrated in FIG. 3, which is about 120 degrees ±5 degrees.


On the radial extreme of each marker 1, 2, 3, and 4, relative to the center of the sphere 20, is optionally a cap 21, 22, 23, and 24. Each cap 21, 22, 23, and 24 has an outer diameter that is greater than the outer diameter of the corresponding marker 1, 2, 3, and 4. The outer diameter dimensions of the markers and caps and the outer diameter of the sphere 20 preferably vary according to the size of the mandrel 10. The size of the mandrel 10 corresponds to the size of the coil 60 that is to be formed with the mandrel 10.


The markers 1, 2, 3, and 4 are disposed on the outer surface of the sphere 20, and each marker 1, 2, 3, and 4 has an outer diameter that is smaller than the outer diameter of the sphere 20, which provides a spacing 70 between each marker 1, 2, 3, and 4 upon the surface of the sphere 20. This spacing 70 between each marker 1, 2, 3, and 4 provides a pathway 72 (FIG. 6) across the surface of the sphere 20 between each marker 1, 2, 3, and 4. The pathway 72 defines the winding pattern 74 (FIGS. 7A and 7B) for a coil 60 that is to be wrapped around the external surface of the sphere 20 in the spacing 70 between each marker 1, 2, 3, and 4.


The diameter of the marker 1, 2, 3, and 4 is selected to provide a coil of a desired softness and strength. The softness of the coil determines the coil's ability to conform to the vascular site. The larger the diameter of the marker 1, 2, 3, and 4, the larger the loop, the softer the coil, and the better the coil is able to conform to the vascular site. In one embodiment of the invention, the ratio of the diameter of the marker 1, 2, 3, and 4 to the diameter of the sphere is from about 0.5 to about 0.75, or 0.55 to about 0.75, or about 0.61 to about 0.65, or about 0.63.


The winding pattern 74 is initiated at the starter tube 40 on marker 1 as shown in FIG. 5. In one embodiment, an end of the coil 60 to be wound is inserted through the starter tube 40 in order to fix the coil 60 relative to the start tube 40. The initial wrap of the coil 60 is made around the outer diameter surface of the marker 1 until achieving a single wrap. A single wrap refers to a wrap that is from 270 circumferential degrees to 360 circumferential degrees. After achieving a single wrap, the coil 60 is wrapped along the pathway 72 disposed along the surface of the sphere 20 in the spacing 70 between adjacent markers 1, 2, 3, and 4, and the pathway 72 is not disposed along the outer diameter surfaces of the markers after the initial wrap.


The winding pattern 74 used for the wrapping of the coil 60 follows the pathway 72 on the external surface of the sphere 20. As illustrated in FIG. 6, the pathway 72 sequentially runs adjacent to each marker 1, 2, 3, and 4 until approaching a midpoint 80 on the surface of the sphere between adjacent markers. As illustrated in FIG. 6, the midpoint 1-3 is disposed at the midpoint 80 between markers 1 and 3 (80 (1-3)). Similar midpoints 80 are located on the sphere between each marker, with a total of six midpoints designated as follows: 1-2 (between markers 1 and 2), 1-3 (between markers 1 and 3), 1-4 (between markers 1 and 4), 2-3 (between markers 2 and 3), 2-4 (between markers 2 and 4), and 3-4 (between markers 3 and 4). When the pathway 72 approaches each midpoint 80, the pathway 72 moves away from a position adjacent to one marker and towards a position adjacent to a different marker. As illustrated in FIG. 6, the pathway 72 travels from a first position 82 adjacent to marker 3 to the midpoint 1-3 and then to a second position 84 adjacent to marker 2.


As can be appreciated from FIGS. 6 and 7A and 7B, the winding pattern 74 follows a pathway 72 that traces a pattern of substantially triangular shapes 90 over the surface of the sphere 20, with each apex 91 of each triangular shape 90 disposed at a midpoint 80. As can be further appreciated, two types of substantially triangular shapes 90 are apparent. One type of substantially triangular shape encloses each marker 1, 2, 3, and 4 and has sides that bow out away from the axes 11, 12, 13, and 14 of the markers. The other type of substantially triangular shape is disposed between the markers 1, 2, 3, and 4 and has sides that correspondingly bow in towards the center of the triangular shape and away from the axes of the markers. As illustrated in FIG. 7A with dashed lines, a total of four outwardly-bowed triangular shapes 92 and a total of four inwardly-bowed triangular shapes 94 are formed, which altogether follow the shape of the outer surface of the sphere 20.


It should be noted that the term “substantially triangular shape” refers to a 3-sided shape wherein the lines defining any or all of the sides are straight, concave or convex. In addition, when the substantially triangular shape is placed on the surface of a sphere, it is understood that the shape so formed will not be 2-dimensional but will otherwise comport to the 3-dimensional surface configuration of the underlying sphere.



FIG. 8 representatively illustrates the winding pattern 74 in regard to the markers 1, 2, 3, and 4 that are passed by the pathway 72. As indicates at the top left corner of FIG. 7A the winding pattern 74 is initiated at marker 1 at the starter tube 40, which is represented by a circle with a number 1, and the initial wind is shown wrapping around marker 1. Subsequent to the initial wind around marker 1, the winding pattern 74 travels to a position adjacent to marker 4, and then to a position adjacent to marker 2, and so on as illustrated. The winding pattern 74 subsequently repeats until the entire coil 60 is wrapped around the mandrel 10. The length of the wrap is dependent on the size of the coil.


The winding pattern 74 can also be represented by reference to the midpoints 80 that are sequentially traversed after the initial wind around marker 1. An initial portion of the winding pattern represented by FIG. 8 can thus be represented by the following pattern of midpoints traversed by winding pattern 74 after the initial wrap around marker 1: 1-4, 2-4, 2-3, 3-4, 2-4, 1-2, 1-3, 3-4, and so on.


When forming the coil 60, the coil is wrapped around the mandrel 10 according to the winding pattern 74, with the beginning of the coil 60 disposed at the starter tube 40 (not shown). When the end the coil 60 is reached in the wrapping process, a portion of the coil 60 is sometimes not wrapped around the sphere 20 and is instead wrapped around the stem 30 (not shown) and stretched to secure the end of the coil in place. FIGS. 9 and 10 show the mandrel 10 and the wrapped coil 60. The wrapped coil 60 is subsequently subjected to a heat treatment process, similar to processes known in the art, that causes the coil 60 to thereafter have a bias to the winding pattern 74 of the mandrel 20, i.e., to have the predisposition to coil in a pattern similar to the winding pattern 74 of the mandrel 20. After the coil 60 has been subjected to the heat treatment process, the coil is removed from the mandrel 20 and further processed. This further processing preferably includes modification described in the next section. Additionally, the coil 60 may comprise a primary structure that is helical.


A coil 60 formed with the mandrel 10, applying the winding pattern 74, and the heat treatment process will have the loop pattern illustrated in FIGS. 7A and B. Preferably, the coil 60 will be biased to form a shape corresponding to the winding pattern 74, with a pattern of eight substantially triangular shapes evenly distributed and spherically curved so as to approximately form the outer diameter shape of the sphere 20, as schematically represented in FIG. 7A. The pattern of the coil 60 will also preferably form a series of four outwardly-bowed substantially triangular shapes corresponding to shapes 92 and a total of four inwardly-bowed substantially triangular shapes corresponding to shapes 94. Depending on the length of the coil 60, at least one and preferably multiple wraps of the coil will be made around the mandrel 10 according to the winding pattern 74, as illustrated in FIGS. 9 and 10.


As illustrated in FIG. 7B, which shows a forward-facing portion of the winding pattern 74 of FIG. 7A with the rearward-facing portion omitted for clarity, the winding pattern 74 includes three loops designated as loop 1, loop 2, and loop 3 that correspond with shapes 92 and 94. As can be appreciated from FIG. 7B, the loop 1, loop 2, and loop 3 portions of the winding pattern 74 follows a path that is disposed between adjacent shapes 92 and 94 that alternate position along the path of loop 1. In the path of loop 1, at point 96, the loop 1 is between a shape 92 on one side and a shape 94 on the other side. Farther along the path of loop 1, at point 98, the relative positions of shapes 92 and 94 to loop 1 have alternated so that loop 1 is between a shape 94 on one side and a shape 92 on the other side. As can also be appreciated from FIGS. 6 and 10, the same alternations of shapes 92 and 94 occur on the rearward-facing portion of the winding pattern 74, and the same alternations of shapes 92 and 94 occur with the loop 2 and loop 3 portions of the winding pattern 74. Yet another thing that can be appreciated from FIGS. 6 and 7A-B, is that the loops 1, 2, and 3 of winding pattern 74 follow paths that curve around the center of the sphere 20 while also curving around at least four points corresponding to shapes 92 and 94, which can be described as generally following the contour of a hyperbolic parabloid or the contour of a saddle. This is shown in FIG. 7B.


Materials

In one embodiment, the coil 60 may be made from a biocompatible metal that does not react adversely with the tissues and fluids when used in the body. The wire may be round, square, oval, triangular, or another shape. In certain embodiments the wire commonly has a diameter of from about 0.025 to about 0.09 mm, from about 0.03 to about 0.08 mm from about 0.04 to about 0.06 mm. In certain specific embodiments, the wire has a diameter of about 0.05 mm. In some embodiments the wire may be comprised only of a primary shape e.g., a simple single helix. In some embodiments the wire component may comprise a primary shape e.g., helical coil and a secondary shape.


In one embodiment, the material of the coil 60 is made of a material that may be heat set at a temperature of approximately 400° C. to about 700° C. In some embodiments, the coil is heat set at about 650° C. The metal or metal alloy can be radiopaque so that the position and location of the implant in the body can be monitored with radiological techniques. Suitable metals include, but are not limited to the noble metals such as the platinum group metals which include platinum, palladium, rhodium and rhenium as well as iridium, gold, silver, tungsten, and tantalum and alloys of these metals with one another. Additional metals include the super elastic metals such as “Nitinol” and the like. In one embodiment, the coil 60 is made of platinum alloy.


The mandrel of the invention may be made from a variety of materials, such as steel, so long as the material selected can withstand the heat set of the coil.


Modifications and Delivery of the Coil

As mentioned above, the coil of the invention may also undergo further processing, including being modified and used with an implant comprising other components. In one embodiment, the implant is modified to include a stretch-resistant member as described in “An Implant Including a Coil and a Stretch Resistant Member,” U.S. Ser. No. 12/038,330, filed Feb. 27, 2008, which is hereby incorporated by reference.


In another embodiment, the coil is coupled with a delivery device. Any delivery device suitable for delivering a coil to a vascular site may be employed. Suitable microcatheters are described in WO 2007/121405 entitled “System and Method For Mechanically Positioning Intravascular Implants” which is hereby incorporated by reference in its entirety.


Regardless of the delivery device employed, after delivery of the implant to the vascular site, the implant substantially conform to the vascular site due to its three-dimensional shape. This is illustrated in FIG. 1D.


EXAMPLES
Example 1
Method of Making the Implant

An implant of the invention may be made by the following procedure.

    • 1. Under microscope insert the distal end of the wire or coil into the starter tube.
    • 2. Wind coil around mandrel as described above and in FIG. 8.
    • 3. Heat set the coil and the mandrel. The temperature is from about 550° C. to about 650° C.


Example 2
Comparison of Other Three-Dimensional Shapes

The coil of the invention was tested and compared with coils having a cubic three-dimensional (3-D) shape and a spherical (or spheroidal) 3-D shape. The clinicians assessed the ability of the coil to compact into the vascular site and the ability of the coil to conform to the shape of the vascular site.


Protocol

The coils of the invention were obtained according to Example 1. The mobius loop coils of the invention were made on a 10 millimeter (mm) sphere with four 8 mm markers. The coils having a cubic 3-D were made by winding wire around a mandrel having six markers (rather than the four to obtain the coils of the invention), one on each face of the cube. One marker was 5 mm and the other five markers were 8 mm. The sphere was 10 mm. The spherical coil were obtained by winding wire around a base mandrel with eight markers. The sphere was again 10 mm and the markers were about 5 mm.


Once the coils were wound according to the patterns above, the coils were heat set at the temperature provided below.


In swine, 10 millimeter aneurysms were created. A 10 millimeter×30 centimeter coil was placed into the aneurysm several times without detaching it and then removing it from the catheter and deploying the next coil. This is illustrated in FIG. 1D.


The clinicians, who tested these coils in a blinded format, then delivered the coil to the aneurysm and provided qualitative feedback regarding the coil. Independent observers then translated each comment into a +1 (good), 0 (neutral), −1 (bad) scale. Some coils were marked with a score higher due to the comments of the doctors. Three of the coils of the mobius loop coils, three of the spherical coils and one of the cubic coils were assessed. Some of the coils tested contained stretch-resistant members as indicated below. The results are presented in Table 1.

















TABLE 1









Stretch
Heat Set
Observer
Observer
Observer





Resistant
Temp.
1
2
3

St.




















Design
Member
(° C.)
1
2
3
1
2
3
1
2
3
Avg.
Dev.























Cubic

670
0
0
1
1
0
−1
−1
1
0
0.11
0.78


Cubic
Nitinol
550
0
0
1
0
1
1
0
1
1
0.56
0.53


Cubic

550
1
1
1.5
0
1
0
1
1
1
0.83
0.50


Cubic
Polypropylene
650
1
0.5
1
1
1
0
1
1
0
0.72
0.44


Mobius

650
0
1
1
1
−1
1
1
1

0.63
0.74


Loop


Mobius

650
1
1
0.5


1
0
1
1
0.79
0.39


Loop


Mobius

550
1
1
1.5
1
0
1
1
1
1
0.94
0.39


Loop


Spherical
Nitinol
550
−1
−1
0
−1
−1
0
−1
−1
1
−0.56
0.73


Spherical

550
0
0
0.5
−1


−1
−1
1
−0.21
0.81









The test was then repeated except the stretch resistant member was varied as indicated. Also, the score were evaluated on a score of 0 (bad) to 5 (good). The results are in Table 2 below.












TABLE 2







Overall
Standard


Design
Stretch-Resistant Member
Performance
deviation


















Cubic
Nitinol
3.0
0.50


Spherical
Nitinol
3.25
0.29


Cubic
Polypropylene
3.67
0.29


Mobius loop
Nitinol
3.75
0.87


Mobius loop
Polypropylene
4.17
0.58









As can be seen in Table 1 and 2, the mobius loop coil is preferred for its overall performance and repeatability over the cubic and spherical coils.


While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims, and equivalents thereof.

Claims
  • 1. An implant comprising: a coil having a coil length that is biased to conform to a winding pattern, the coil comprising a primary, substantially linear configuration for delivery of the coil to a vascular site, and a secondary, substantially spherical configuration in an unrestrained state for positioning at said vascular site, the winding pattern approximately conforming to an outer surface of a sphere, the winding pattern consisting of only substantially triangular shapes, each triangular shape having a center, four of the triangular shapes having sides that bow outward away from the center, four of the triangular shapes having sides that bow inward towards the center, the coil comprising a proximal end, a distal end, and a longitudinal axis that, when the coil is in the linear configuration, extends from the proximal end to the distal end, the coil formed by winding about a mandrel and twisting the proximal end at least half a turn with respect to the distal end about the longitudinal axis.
  • 2. The implant of claim 1, wherein the coil substantially conforms to a vascular site.
  • 3. The implant of claim 1, wherein the coil is comprised of a metal wire.
  • 4. The implant of claim 3, wherein the wire is comprised of a metal selected from the group consisting of platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten, tantalum, an alloy of two or more of these metals, or a super elastic metal.
  • 5. The implant of claim 4, wherein the wire is a platinum alloy.
  • 6. A method of embolizing a vascular site of a patient comprising delivering an implant of claim 1 via a delivery device to the vascular site thereby embolizing the vascular site.
  • 7. The method of claim 6, wherein the implant substantially conforms to the vascular site.
  • 8. The method of claim 7 comprising delivering additional implants to the vascular site.
  • 9. An implant comprising: a coil having a coil length that is biased to conform to a winding pattern, the coil comprising a primary, substantially linear configuration for delivery of the coil to a vascular site, and a secondary, substantially spherical configuration in an unrestrained state for positioning at said vascular site, the winding pattern approximately conforming to an outer surface of a sphere, the winding pattern consisting of only substantially triangular shapes, each triangular shape having a center, four of the triangular shapes having sides that bow outward away from the center, four of the triangular shapes having sides that bow inward towards the center.
  • 10. The implant of claim 9, wherein the coil substantially conforms to a vascular site.
  • 11. The implant of claim 9, wherein the coil is comprised of a metal wire.
  • 12. The implant of claim 11, wherein the wire is comprised of a metal selected from the group consisting of platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten, tantalum, an alloy of two or more of these metals, or a super elastic metal.
  • 13. The implant of claim 12 wherein the wire is a platinum alloy.
  • 14. A method of embolizing a vascular site of a patient comprising delivering an implant of claim 9 via a delivery device to the vascular site thereby embolizing the vascular site.
  • 15. The method of claim 14, wherein the implant substantially conforms to the vascular site.
  • 16. The method of claim 15 comprising delivering additional implants to the vascular site.
RELATED APPLICATIONS

This application claims the benefit under 35 U.S.C. §119(e) of provisional application Ser. Nos. 60/894,589 filed Mar. 13, 2007, 60/894,865 and 60/894,858 both filed on Mar. 14, 2007, all of which are hereby incorporated by reference in their entirety.

US Referenced Citations (540)
Number Name Date Kind
3334629 Colm Aug 1967 A
3834394 Hunter et al. Sep 1974 A
4085757 Pevsner Apr 1978 A
4282875 Serbinenko et al. Aug 1981 A
4311146 Wonder Jan 1982 A
4327734 White, Jr. May 1982 A
4341218 U Jul 1982 A
4346712 Handa et al. Aug 1982 A
4364392 Strother et al. Dec 1982 A
4402319 Handa et al. Sep 1983 A
4441495 Hicswa Apr 1984 A
4494531 Gianturco Jan 1985 A
4517979 Pecenka May 1985 A
4545367 Tucci Oct 1985 A
4638803 Rand Jan 1987 A
4719924 Crittenden et al. Jan 1988 A
4735201 O'Reilly Apr 1988 A
4745919 Bundy et al. May 1988 A
4781177 Lebigot Nov 1988 A
4787899 Lazarus Nov 1988 A
4819637 Dormandy, Jr. et al. Apr 1989 A
4832055 Palestrant May 1989 A
4932419 de Toledo Jun 1990 A
4944746 Iwata et al. Jul 1990 A
4957501 Lahille et al. Sep 1990 A
4990155 Wilkoff Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
5002556 Ishida et al. Mar 1991 A
5026377 Burton et al. Jun 1991 A
5035706 Giantureo et al. Jul 1991 A
5037427 Harada et al. Aug 1991 A
5062829 Pryor et al. Nov 1991 A
5104399 Lazarus Apr 1992 A
5108407 Geremia et al. Apr 1992 A
5109867 Twyford, Jr. May 1992 A
5122136 Guglielmi et al. Jun 1992 A
5133731 Butler et al. Jul 1992 A
5133732 Wiktor Jul 1992 A
5147370 McNamara et al. Sep 1992 A
5167624 Butler et al. Dec 1992 A
5181921 Makita et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5211658 Clouse May 1993 A
5217484 Marks Jun 1993 A
5222970 Reeves Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226911 Chee et al. Jul 1993 A
5234437 Sepetka Aug 1993 A
5250071 Palermo Oct 1993 A
5256146 Ensminger et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5263964 Purdy Nov 1993 A
5304194 Chee et al. Apr 1994 A
5304195 Twyford, Jr. et al. Apr 1994 A
5312415 Palermo May 1994 A
5314472 Fontaine May 1994 A
5334210 Gianturco Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5368592 Stern et al. Nov 1994 A
5382259 Phelps et al. Jan 1995 A
5382260 Dormandy, Jr. et al. Jan 1995 A
5382261 Palmaz Jan 1995 A
5397345 Lazarus Mar 1995 A
5417708 Hall et al. May 1995 A
5423829 Pham et al. Jun 1995 A
5423849 Engelson et al. Jun 1995 A
5443454 Tanabe et al. Aug 1995 A
5443478 Purdy Aug 1995 A
5456693 Conston et al. Oct 1995 A
5476472 Dormandy, Jr. et al. Dec 1995 A
5480382 Hammerslag et al. Jan 1996 A
5498227 Mawad Mar 1996 A
5507769 Marin et al. Apr 1996 A
5522822 Phelps et al. Jun 1996 A
5522836 Palermo Jun 1996 A
5527338 Purdy Jun 1996 A
5536274 Neuss Jul 1996 A
5540680 Guglielmi et al. Jul 1996 A
5549624 Mirigian et al. Aug 1996 A
5556426 Popadiuk et al. Sep 1996 A
5562698 Parker Oct 1996 A
5569245 Guglielmi et al. Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5578074 Mirigian Nov 1996 A
5582619 Ken Dec 1996 A
5601600 Ton Feb 1997 A
5624449 Pham et al. Apr 1997 A
5624461 Mariant Apr 1997 A
5626599 Bourne et al. May 1997 A
5634928 Fischell et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5643254 Scheldrup et al. Jul 1997 A
5645558 Horton Jul 1997 A
5645564 Northrup et al. Jul 1997 A
5649949 Wallace et al. Jul 1997 A
5658308 Snyder Aug 1997 A
5662700 Lazarus Sep 1997 A
5669905 Scheldrup et al. Sep 1997 A
5669931 Kupiecki et al. Sep 1997 A
5690666 Berenstein et al. Nov 1997 A
5690667 Gia Nov 1997 A
5690671 McGurk et al. Nov 1997 A
5693067 Purdy Dec 1997 A
5695517 Marin et al. Dec 1997 A
5700258 Mirigian et al. Dec 1997 A
5702361 Evans et al. Dec 1997 A
5718711 Berenstein et al. Feb 1998 A
5725534 Rasmussen Mar 1998 A
5725546 Samson Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5746734 Dormandy, Jr. et al. May 1998 A
5746769 Ton et al. May 1998 A
5749891 Ken et al. May 1998 A
5749894 Engelson May 1998 A
5749918 Hogendijk et al. May 1998 A
5759161 Ogawa et al. Jun 1998 A
5766219 Horton Jun 1998 A
5797953 Tekulve Aug 1998 A
5800426 Taki et al. Sep 1998 A
5800453 Gia Sep 1998 A
5800455 Palermo et al. Sep 1998 A
5814062 Sepetka et al. Sep 1998 A
5830230 Berryman et al. Nov 1998 A
5833705 Ken et al. Nov 1998 A
5843118 Sepetka et al. Dec 1998 A
5846210 Ogawa et al. Dec 1998 A
5851206 Guglielmi et al. Dec 1998 A
5853418 Ken et al. Dec 1998 A
5855578 Guglielmi et al. Jan 1999 A
5891058 Taki et al. Apr 1999 A
5891128 Gia et al. Apr 1999 A
5891130 Palermo et al. Apr 1999 A
5891155 Irie Apr 1999 A
5891192 Murayama et al. Apr 1999 A
5895385 Guglielmi et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5895410 Forber et al. Apr 1999 A
5895411 Irie Apr 1999 A
5911731 Pham et al. Jun 1999 A
5911737 Lee et al. Jun 1999 A
5916235 Guglielmi Jun 1999 A
5919187 Guglielmi et al. Jul 1999 A
5925037 Guglielmi et al. Jul 1999 A
5925059 Palermo et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5928226 Guglielmi et al. Jul 1999 A
5935145 Villar et al. Aug 1999 A
5935148 Villar et al. Aug 1999 A
5941249 Maynard Aug 1999 A
5941888 Wallace et al. Aug 1999 A
5944714 Guglielmi et al. Aug 1999 A
5944733 Engelson Aug 1999 A
5947962 Guglielmi et al. Sep 1999 A
5947963 Guglielmi Sep 1999 A
5957948 Mariant Sep 1999 A
5964797 Ho Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976126 Guglielmi Nov 1999 A
5976131 Guglielmi et al. Nov 1999 A
5976152 Regan et al. Nov 1999 A
5976162 Doan et al. Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980550 Eder et al. Nov 1999 A
5980554 Lenker et al. Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
5984944 Forber Nov 1999 A
5989242 Saadat et al. Nov 1999 A
6001092 Mirigian et al. Dec 1999 A
6004338 Ken et al. Dec 1999 A
6010498 Guglielmi Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6017364 Lazarus Jan 2000 A
6017977 Evans et al. Jan 2000 A
6019757 Scheldrup Feb 2000 A
6019779 Thorud et al. Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6024754 Engelson Feb 2000 A
6024765 Wallace et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033423 Ken et al. Mar 2000 A
6039749 Marin et al. Mar 2000 A
6056770 Epstein et al. May 2000 A
6059779 Mills May 2000 A
6059815 Lee et al. May 2000 A
6063070 Eder May 2000 A
6063100 Diaz et al. May 2000 A
6063104 Villar et al. May 2000 A
6066133 Guglielmi et al. May 2000 A
6066149 Samson et al. May 2000 A
6068644 Lulo et al. May 2000 A
6074407 Levine et al. Jun 2000 A
6077260 Wheelock et al. Jun 2000 A
D427680 Mariant et al. Jul 2000 S
6083220 Guglielmi et al. Jul 2000 A
6086577 Ken et al. Jul 2000 A
6090125 Horton Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096034 Kupiecki et al. Aug 2000 A
6099546 Gia Aug 2000 A
6102917 Maitland et al. Aug 2000 A
6102932 Kurz Aug 2000 A
6102933 Lee et al. Aug 2000 A
6113622 Hieshima Sep 2000 A
6117142 Goodson et al. Sep 2000 A
6117157 Tekulve Sep 2000 A
6123714 Gia et al. Sep 2000 A
6126672 Berryman et al. Oct 2000 A
6136015 Kurz et al. Oct 2000 A
6143007 Mariant et al. Nov 2000 A
6146373 Cragg et al. Nov 2000 A
6149664 Kurz Nov 2000 A
6149681 Houser et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6159165 Ferrera et al. Dec 2000 A
6159206 Ogawa Dec 2000 A
6165178 Bashiri et al. Dec 2000 A
6165193 Greene, Jr. et al. Dec 2000 A
6165198 McGurk et al. Dec 2000 A
6168570 Ferrera Jan 2001 B1
6168592 Kupiecki et al. Jan 2001 B1
6168610 Marin et al. Jan 2001 B1
6168615 Ken et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6171326 Ferrera et al. Jan 2001 B1
6183491 Lulo Feb 2001 B1
6183495 Lenker et al. Feb 2001 B1
6187024 Boock et al. Feb 2001 B1
6187027 Mariant et al. Feb 2001 B1
6190373 Palermo et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6193728 Ken et al. Feb 2001 B1
RE37117 Palermo Mar 2001 E
6202261 Moore et al. Mar 2001 B1
6203547 Nguyen et al. Mar 2001 B1
6221066 Ferrera et al. Apr 2001 B1
6221086 Forber Apr 2001 B1
6224610 Ferrera May 2001 B1
6231573 Amor et al. May 2001 B1
6231586 Mariant May 2001 B1
6231590 Slaikeu et al. May 2001 B1
6231597 Deem et al. May 2001 B1
6238403 Greene, Jr. et al. May 2001 B1
6238415 Sepetka et al. May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6254592 Samson et al. Jul 2001 B1
6270495 Palermo Aug 2001 B1
6277125 Barry et al. Aug 2001 B1
6277126 Barry et al. Aug 2001 B1
6280457 Wallace et al. Aug 2001 B1
6281263 Evans et al. Aug 2001 B1
6287315 Wijeratne et al. Sep 2001 B1
6287318 Villar et al. Sep 2001 B1
6293960 Ken Sep 2001 B1
6296622 Kurz et al. Oct 2001 B1
6299619 Greene, Jr. et al. Oct 2001 B1
6299627 Eder et al. Oct 2001 B1
6306153 Kurz et al. Oct 2001 B1
6312405 Meyer et al. Nov 2001 B1
6312421 Boock Nov 2001 B1
6315709 Garibaldi et al. Nov 2001 B1
6319267 Kurz Nov 2001 B1
6322576 Wallace et al. Nov 2001 B1
6328750 Berry et al. Dec 2001 B1
6331184 Abrams Dec 2001 B1
6335384 Evans et al. Jan 2002 B1
6344041 Kupiecki et al. Feb 2002 B1
6344048 Chin et al. Feb 2002 B1
6346091 Jacobsen et al. Feb 2002 B1
6346117 Greenhalgh Feb 2002 B1
6348041 Klint Feb 2002 B1
6361547 Hieshima Mar 2002 B1
6364823 Garibaldi et al. Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371972 Wallace et al. Apr 2002 B1
6375606 Garibaldi et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6375668 Gifford et al. Apr 2002 B1
6375669 Rosenbluth et al. Apr 2002 B1
6379329 Naglreiter et al. Apr 2002 B1
6379374 Hieshima et al. Apr 2002 B1
6383146 Klint May 2002 B1
6383174 Eder May 2002 B1
6383204 Ferrera et al. May 2002 B1
6383205 Samson et al. May 2002 B1
6409721 Wheelock et al. Jun 2002 B1
6416535 Lazarus Jul 2002 B1
6416541 Denardo Jul 2002 B2
6423085 Murayama et al. Jul 2002 B1
6425893 Guglielmi Jul 2002 B1
6425914 Wallace et al. Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6454780 Wallace Sep 2002 B1
6458119 Berenstein et al. Oct 2002 B1
6458127 Truckai et al. Oct 2002 B1
6458137 Klint Oct 2002 B1
6464699 Swanson Oct 2002 B1
6468266 Bashiri et al. Oct 2002 B1
6475169 Ferrera Nov 2002 B2
6475227 Burke et al. Nov 2002 B2
6478773 Gandhi et al. Nov 2002 B1
6485524 Strecker Nov 2002 B2
6494884 Gifford, III et al. Dec 2002 B2
6500149 Gandhi et al. Dec 2002 B2
6500190 Greene, Jr. et al. Dec 2002 B2
6506204 Mazzocchi Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6514264 Naglreiter Feb 2003 B1
6530934 Jacobsen et al. Mar 2003 B1
6533801 Wallace et al. Mar 2003 B2
6537293 Berryman et al. Mar 2003 B1
6540657 Cross, III et al. Apr 2003 B2
6544163 Wallace et al. Apr 2003 B2
6544225 Lulo et al. Apr 2003 B1
6544268 Lazarus Apr 2003 B1
6544275 Teoh Apr 2003 B1
6547804 Porter et al. Apr 2003 B2
6551305 Ferrera et al. Apr 2003 B2
6551340 Konya et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6558367 Cragg et al. May 2003 B1
6569179 Teoh et al. May 2003 B2
6572628 Dominguez et al. Jun 2003 B2
6575994 Marin et al. Jun 2003 B1
6585748 Jeffree Jul 2003 B1
6585754 Wallace et al. Jul 2003 B2
6589227 Sønderskov Klint Jul 2003 B2
6589230 Gia et al. Jul 2003 B2
6589236 Wheelock et al. Jul 2003 B2
6589265 Palmer et al. Jul 2003 B1
6592605 Lenker et al. Jul 2003 B2
6602261 Greene et al. Aug 2003 B2
6602269 Wallace et al. Aug 2003 B2
6603994 Wallace et al. Aug 2003 B2
6605101 Schaefer et al. Aug 2003 B1
6607538 Ferrera et al. Aug 2003 B1
6607539 Hayashi et al. Aug 2003 B1
6610085 Lazarus Aug 2003 B1
6613074 Mitelberg et al. Sep 2003 B1
6616617 Ferrera et al. Sep 2003 B1
6620152 Guglielmi Sep 2003 B2
6623493 Wallace et al. Sep 2003 B2
6632241 Hancock et al. Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6635069 Teoh et al. Oct 2003 B1
6638291 Ferrera et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6656173 Palermo Dec 2003 B1
6656201 Ferrera et al. Dec 2003 B2
6656218 Denardo et al. Dec 2003 B1
6656351 Boyle Dec 2003 B2
6660020 Wallace et al. Dec 2003 B2
6663607 Slaikeu et al. Dec 2003 B2
6679903 Kurz Jan 2004 B2
6685653 Ehr et al. Feb 2004 B2
6685696 Fleischhacker et al. Feb 2004 B2
6689141 Ferrera et al. Feb 2004 B2
6692510 West Feb 2004 B2
6702844 Lazarus Mar 2004 B1
6716238 Elliott Apr 2004 B2
6723112 Ho et al. Apr 2004 B2
6743236 Barry et al. Jun 2004 B2
6743251 Eder Jun 2004 B1
6767358 Leonhardt et al. Jul 2004 B2
6811561 Diaz et al. Nov 2004 B2
6814748 Baker et al. Nov 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6849081 Sepetka et al. Feb 2005 B2
6852116 Leonhardt et al. Feb 2005 B2
6853418 Suzuki et al. Feb 2005 B2
6855153 Saadat Feb 2005 B2
6855155 Denardo et al. Feb 2005 B2
6860893 Wallace et al. Mar 2005 B2
6860901 Baker et al. Mar 2005 B1
6872218 Ferrera et al. Mar 2005 B2
6878163 Denardo et al. Apr 2005 B2
6905503 Gifford, III et al. Jun 2005 B2
6913618 Denardo et al. Jul 2005 B2
6929654 Teoh et al. Aug 2005 B2
6945956 Waldhauser et al. Sep 2005 B2
6958061 Truckai et al. Oct 2005 B2
6958068 Hieshima Oct 2005 B2
6964657 Cragg et al. Nov 2005 B2
6966892 Gandhi et al. Nov 2005 B2
6984240 Ken et al. Jan 2006 B1
6994711 Hieshima et al. Feb 2006 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7029486 Schaefer et al. Apr 2006 B2
7029487 Greene, Jr. et al. Apr 2006 B2
7033374 Schaefer et al. Apr 2006 B2
7058456 Pierce Jun 2006 B2
7060083 Gerberding Jun 2006 B2
7070607 Murayama et al. Jul 2006 B2
7147618 Kurz Dec 2006 B2
7169161 Bonnette et al. Jan 2007 B2
7182774 Barry et al. Feb 2007 B2
7198613 Gandhi et al. Apr 2007 B2
7238194 Monstadt et al. Jul 2007 B2
7300458 Henkes et al. Nov 2007 B2
7316701 Ferrera et al. Jan 2008 B2
7323000 Monstadt et al. Jan 2008 B2
7331973 Gesswein et al. Feb 2008 B2
7344558 Lorenzo et al. Mar 2008 B2
7410482 Murphy et al. Aug 2008 B2
7473266 Glaser Jan 2009 B2
7485122 Teoh Feb 2009 B2
7485317 Murayama et al. Feb 2009 B1
7524322 Monstadt et al. Apr 2009 B2
7575582 Gandhi et al. Aug 2009 B2
7578826 Gandhi et al. Aug 2009 B2
RE41029 Guglielmi et al. Dec 2009 E
7691124 Balgobin Apr 2010 B2
7708755 Davis, III et al. May 2010 B2
7722636 Farnan May 2010 B2
7722637 Barry et al. May 2010 B2
7766933 Davis, III et al. Aug 2010 B2
7811305 Balgobin et al. Oct 2010 B2
7841994 Skujins et al. Nov 2010 B2
7879064 Monstadt et al. Feb 2011 B2
7883526 Jones et al. Feb 2011 B2
7896899 Patterson et al. Mar 2011 B2
7901444 Slazas Mar 2011 B2
7901704 Richard Mar 2011 B2
7918872 Mitelberg et al. Apr 2011 B2
7938845 Aganon et al. May 2011 B2
7955272 Rooney et al. Jun 2011 B2
8002789 Ramzipoor et al. Aug 2011 B2
8007509 Buiser et al. Aug 2011 B2
8372110 Monstadt et al. Feb 2013 B2
20020010481 Jayaraman Jan 2002 A1
20020019647 Wallace et al. Feb 2002 A1
20020065529 Laurent et al. May 2002 A1
20020072712 Nool et al. Jun 2002 A1
20020072791 Eder et al. Jun 2002 A1
20020082620 Lee Jun 2002 A1
20020087184 Eder et al. Jul 2002 A1
20020120297 Shadduck Aug 2002 A1
20020128671 Wallace et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020143349 Gifford, III et al. Oct 2002 A1
20020169473 Sepetka et al. Nov 2002 A1
20030014073 Bashiri et al. Jan 2003 A1
20030040733 Cragg et al. Feb 2003 A1
20030045901 Opolski Mar 2003 A1
20030083676 Wallace May 2003 A1
20030130689 Wallace et al. Jul 2003 A1
20030169473 Cotter et al. Sep 2003 A1
20030176857 Lee Sep 2003 A1
20030181927 Wallace Sep 2003 A1
20030216772 Konya et al. Nov 2003 A1
20030225365 Greff et al. Dec 2003 A1
20040002731 Aganon et al. Jan 2004 A1
20040002732 Teoh et al. Jan 2004 A1
20040002733 Teoh Jan 2004 A1
20040006362 Schaefer et al. Jan 2004 A1
20040006363 Schaefer Jan 2004 A1
20040024394 Wallace et al. Feb 2004 A1
20040034363 Wilson et al. Feb 2004 A1
20040034378 Monstadt et al. Feb 2004 A1
20040045554 Schaefer et al. Mar 2004 A1
20040078050 Monstadt et al. Apr 2004 A1
20040106946 Ferrera et al. Jun 2004 A1
20040181256 Glaser Sep 2004 A1
20040193178 Nikolchev Sep 2004 A1
20040193206 Gerberding et al. Sep 2004 A1
20040220563 Eder Nov 2004 A1
20040220585 Nikolchev Nov 2004 A1
20040225279 Raymond Nov 2004 A1
20040236344 Monstadt et al. Nov 2004 A1
20040260384 Allen Dec 2004 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050021074 Elliott Jan 2005 A1
20050079196 Henkes et al. Apr 2005 A1
20050171572 Martinez Aug 2005 A1
20050177185 Becker et al. Aug 2005 A1
20060025801 Lulo et al. Feb 2006 A1
20060025802 Sowers Feb 2006 A1
20060036281 Patterson et al. Feb 2006 A1
20060079926 Desai et al. Apr 2006 A1
20060106417 Tessmer et al. May 2006 A1
20060116711 Elliott et al. Jun 2006 A1
20060116714 Sepetka et al. Jun 2006 A1
20060200190 Lorenzo et al. Sep 2006 A1
20060271097 Ramzipoor et al. Nov 2006 A1
20060276824 Mitelberg Dec 2006 A1
20070055302 Henry et al. Mar 2007 A1
20070083226 Buiser et al. Apr 2007 A1
20070142893 Buiser et al. Jun 2007 A1
20070150045 Ferrera Jun 2007 A1
20070173757 Levine et al. Jul 2007 A1
20070185524 Diaz et al. Aug 2007 A1
20070225738 Pal Sep 2007 A1
20070239193 Simon et al. Oct 2007 A1
20070239199 Jayaraman Oct 2007 A1
20070282425 Kleine et al. Dec 2007 A1
20070299461 Elliott Dec 2007 A1
20080045922 Cragg et al. Feb 2008 A1
20080046092 Davis et al. Feb 2008 A1
20080046093 Davis et al. Feb 2008 A1
20080051803 Monstadt et al. Feb 2008 A1
20080097462 Mitelberg et al. Apr 2008 A1
20080103585 Monstadt et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080228215 Strauss et al. Sep 2008 A1
20080300616 Que et al. Dec 2008 A1
20080306504 Win et al. Dec 2008 A1
20080319532 Monstadt et al. Dec 2008 A1
20090069836 Labdag et al. Mar 2009 A1
20090149864 Porter Jun 2009 A1
20090182268 Thielen et al. Jul 2009 A1
20090254111 Monstadt et al. Oct 2009 A1
20090254169 Spenser et al. Oct 2009 A1
20090270877 Johnson et al. Oct 2009 A1
20090312748 Johnson et al. Dec 2009 A1
20100004673 Denison et al. Jan 2010 A1
20100004675 Wilson et al. Jan 2010 A1
20100023105 Levy et al. Jan 2010 A1
20100030200 Strauss et al. Feb 2010 A1
20100030319 Weber Feb 2010 A1
20100049165 Sutherland et al. Feb 2010 A1
20100076479 Monstadt Mar 2010 A1
20100174269 Tompkins et al. Jul 2010 A1
20110022003 Tekulve Jan 2011 A1
20110098814 Monstadt et al. Apr 2011 A1
20110118777 Patterson et al. May 2011 A1
20110172700 Bose et al. Jul 2011 A1
20110184454 Barry et al. Jul 2011 A1
20110213406 Aganon et al. Sep 2011 A1
20110313447 Strauss Dec 2011 A1
20120041470 Shrivastava et al. Feb 2012 A1
20120065720 Strauss et al. Mar 2012 A1
20120226305 Strauss et al. Sep 2012 A1
20120313447 Park et al. Dec 2012 A1
20130190801 Divino et al. Jul 2013 A1
20130253572 Molaei et al. Sep 2013 A1
Foreign Referenced Citations (159)
Number Date Country
2144725 May 1994 CA
2265062 Sep 1999 CA
1668250 Sep 2005 CN
4445715 Jun 1996 DE
69627243 Jan 1997 DE
195 47 617 Sep 1997 DE
19607451 Sep 1997 DE
19610333 Sep 1997 DE
19647280 Oct 1997 DE
19952387 May 2001 DE
10010840 Sep 2001 DE
10118017 Oct 2002 DE
10155191 May 2003 DE
707830 Apr 1996 EP
711532 May 1996 EP
717969 Jun 1996 EP
720838 Jul 1996 EP
765636 Jul 1997 EP
792623 Sep 1997 EP
820726 Jan 1998 EP
829236 Mar 1998 EP
830873 Mar 1998 EP
0 832 607 Apr 1998 EP
832607 Apr 1998 EP
0 853 955 Jul 1998 EP
865773 Sep 1998 EP
882428 Sep 1998 EP
904737 Mar 1999 EP
941700 Sep 1999 EP
941701 Sep 1999 EP
914807 Dec 1999 EP
992220 Apr 2000 EP
996372 May 2000 EP
1005837 Jun 2000 EP
1120088 Aug 2001 EP
1125553 Aug 2001 EP
1129666 Sep 2001 EP
1142535 Oct 2001 EP
1169969 Jan 2002 EP
1188413 Mar 2002 EP
1188414 Mar 2002 EP
1295563 Mar 2003 EP
1312312 May 2003 EP
1316293 Jun 2003 EP
1358850 Nov 2003 EP
1374801 Jan 2004 EP
1 487 526 Dec 2004 EP
1 669 032 Jun 2006 EP
1 738 698 Jan 2007 EP
2292147 Mar 2011 EP
6-246004 Sep 1994 JP
7-155331 Jun 1995 JP
7-265431 Oct 1995 JP
7-284534 Oct 1995 JP
9-168541 Jun 1997 JP
10-127646 May 1998 JP
10-201766 Aug 1998 JP
11-47138 Feb 1999 JP
11-76249 Mar 1999 JP
2001-513389 Sep 2001 JP
2002-523172 Jul 2002 JP
2004-500929 Jan 2004 JP
2006-051349 Feb 2006 JP
2008-525113 Jul 2008 JP
2010107255 Oct 2010 KR
10-1014547 Feb 2011 KR
WO 8803817 Jun 1988 WO
WO 8906984 Aug 1989 WO
WO 9012616 Nov 1990 WO
WO 9113592 Sep 1991 WO
WO 9214408 Sep 1992 WO
WO 9221400 Dec 1992 WO
WO 9311719 Jun 1993 WO
WO 9316650 Sep 1993 WO
WO 9406502 Mar 1994 WO
WO 9406503 Mar 1994 WO
WO 9410936 May 1994 WO
WO 9411051 May 1994 WO
WO 9426175 Nov 1994 WO
WO 9512367 May 1995 WO
WO 9618343 Jun 1996 WO
WO 9632153 Oct 1996 WO
WO 9639950 Dec 1996 WO
WO 9727888 Aug 1997 WO
WO 9742881 Nov 1997 WO
WO 9809570 Mar 1998 WO
WO 9817183 Apr 1998 WO
WO 9833452 Aug 1998 WO
WO-9834546 Aug 1998 WO
WO 9839048 Sep 1998 WO
WO 9858590 Dec 1998 WO
WO 9902094 Jan 1999 WO
WO 9905977 Feb 1999 WO
WO 9907292 Feb 1999 WO
WO 9909893 Mar 1999 WO
WO-9909893 Mar 1999 WO
WO 9932037 Jul 1999 WO
WO 9942038 Aug 1999 WO
WO 9944538 Sep 1999 WO
WO-9949812 Oct 1999 WO
WO 9956636 Nov 1999 WO
WO 0012016 Mar 2000 WO
WO 0013593 Mar 2000 WO
WO 0025680 May 2000 WO
WO 0044306 Aug 2000 WO
WO 0072781 Dec 2000 WO
WO 0132085 May 2001 WO
WO 0156500 Aug 2001 WO
WO 0158365 Aug 2001 WO
WO-0158382 Aug 2001 WO
WO 0187184 Nov 2001 WO
WO-0193937 Dec 2001 WO
WO 0193937 Dec 2001 WO
WO 0202018 Jan 2002 WO
WO 0213705 Feb 2002 WO
WO 0213706 Feb 2002 WO
WO 0232496 Apr 2002 WO
WO 0239911 May 2002 WO
WO 0241753 May 2002 WO
WO 0245596 Jun 2002 WO
WO 02054943 Jul 2002 WO
WO 02054980 Jul 2002 WO
WO 02072168 Sep 2002 WO
WO 02087449 Nov 2002 WO
WO 02087651 Nov 2002 WO
WO 02089676 Nov 2002 WO
WO 02096273 Dec 2002 WO
WO 02096301 Dec 2002 WO
WO 03001970 Jan 2003 WO
WO 03007823 Jan 2003 WO
WO 03017852 Mar 2003 WO
WO 03034927 May 2003 WO
WO 03039624 May 2003 WO
WO 03041615 May 2003 WO
WO 03053257 Jul 2003 WO
WO 03053281 Jul 2003 WO
WO 03073914 Sep 2003 WO
WO 03077776 Sep 2003 WO
WO 03077984 Sep 2003 WO
WO 03082128 Oct 2003 WO
WO 03086240 Oct 2003 WO
WO 03092547 Nov 2003 WO
WO 03099370 Dec 2003 WO
WO 2004008974 Jan 2004 WO
WO 2004014239 Feb 2004 WO
WO 2004069059 Feb 2004 WO
WO 2004069538 Aug 2004 WO
WO 2004073529 Sep 2004 WO
WO-2005065556 Jul 2005 WO
WO-2006058042 Jun 2006 WO
WO-2006069123 Jun 2006 WO
WO 2007121405 Oct 2007 WO
WO 2008112435 Sep 2008 WO
WO-2008112436 Sep 2008 WO
WO-2008127328 Oct 2008 WO
WO-2010117883 Oct 2010 WO
WO-2010123821 Oct 2010 WO
WO-2010134914 Nov 2010 WO
WO-2011030820 Mar 2011 WO
Non-Patent Literature Citations (12)
Entry
Meriam-Webster dictionary definition for “twist”.
US 6,056,761, 05/2000, Gia et al. (withdrawn).
U.S. Appl. No. 12/297,419, filed Apr. 16, 2007, Strauss, et al.
U.S. Appl. No. 12/038,730, filed Feb. 27, 2008, Strauss et al.
International Search Report dated Sep. 10, 2008.
International Search Report dated Sep. 26, 2008.
Office Action (including English Translation) for Chinese Patent Application No. 200780018622.5 dated Aug. 2, 2010 in 8 total pages.
Copending U.S. Appl. No. 12/981,286, filed Dec. 29, 2010 (010C1).
Copending U.S. Appl. No. 13/010,671, filed Jan. 20, 2011 (012C1).
U.S. Appl. No. 13/308,476, filed Nov. 30, 2011.
U.S. Appl. No. 13/685,754, filed Nov. 27, 2012.
U.S. Appl. No. 13/841,836, filed Mar. 15, 2013.
Related Publications (1)
Number Date Country
20080228216 A1 Sep 2008 US
Provisional Applications (3)
Number Date Country
60894589 Mar 2007 US
60894858 Mar 2007 US
60894865 Mar 2007 US